(13)C-phenylalanine breath test correlates with liver fibrosis in postoperative biliary atresia

Masaki Wada1, Yuko Wada, Makoto Uchiyama

  • 1Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. nicuwada@tymc.twmu.ac.jp

Insights

The (13)C-phenylalanine breath test (PBT) effectively assesses liver fibrosis in children post-biliary atresia surgery. This non-invasive PBT method provides reliable liver function monitoring for pediatric patients with liver fibrosis.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Biochemical Testing

Background:

  • The (13)C-phenylalanine breath test (PBT) is a validated index for assessing liver fibrosis and predicting liver disease in adults.
  • Biliary atresia (BA) is a serious condition in children requiring surgical intervention and subsequent monitoring for liver complications.
  • Evaluating liver function and fibrosis in pediatric patients post-BA surgery is crucial for long-term health outcomes.

Purpose of the Study:

  • To evaluate phenylalanine metabolism in the liver of children who underwent surgery for biliary atresia (BA).
  • To compare (13)C-phenylalanine breath test (PBT) findings with biochemical data, particularly liver fibrosis indices, in postoperative BA children.
  • To determine the utility of PBT as a non-invasive tool for monitoring liver fibrosis in this pediatric population.

Main Methods:

  • Hepatofunctional evaluations and (13)C-phenylalanine breath tests (PBT) were performed on 10 postoperative BA children (moderate and severe liver dysfunction) and 13 healthy children.
  • Participants received a single oral dose of (13)C-phenylalanine (3.5 mg/kg).
  • Exhaled gas was collected for 120 minutes post-administration, with (13)CO(2) levels monitored using gas chromatography-mass spectrometry to assess phenylalanine metabolism.

Main Results:

  • Significant correlations were observed between PBT findings and established liver fibrosis markers, including total bile acid, hyaluronic acid, type IV collagen 7S, total bilirubin, and albumin.
  • PBT results were significantly lower in children with severe liver dysfunction (Group A) compared to those with moderate dysfunction (Group B).
  • These findings indicate markedly attenuated phenylalanine metabolism in children with more severe liver dysfunction.

Conclusions:

  • The (13)C-phenylalanine breath test (PBT) values demonstrated a strong correlation with liver fibrosis in children following biliary atresia surgery.
  • PBT serves as a valuable, non-invasive method for assessing liver fibrosis.
  • The study supports the use of PBT as a reliable index for post-surgical monitoring of liver fibrosis in pediatric patients.
Abstract